BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2001
View Archived Issues
Potent, selective and orally bioavailable CCR5 antagonist obtained at Schering-Plough
Read More
Additional patient enrollment suspended in phase III study of Aptosyn and Taxotere
Read More
Safer NSAIDs designed by linking ibuprofen to furoxan moieties
Read More
Genentech and Xoma to include additional study in Xanelim BLA submission to FDA
Read More
Folate-based thymidylate synthase inhibitor CW-252053 safe and effective in tumor-bearing mice
Read More
NeoPharm initiates phase I/II clinical trial for LEM in cancer
Read More
Positive results shown in preliminary analysis of phase II PTI-555 trial
Read More
Experimental dog model of osteoarthritis used to evaluate therapeutic effects of ML-3000
Read More
AtheroGenics reacquires rights to AGI-1067 from Schering-Plough
Read More
Pfizer's voriconazole recommended for treatment of acute invasive aspergillosis
Read More
Chondrocyte damage induced by proinflammatory cytokine attenuated by PBN
Read More
Nastech initiates phase I clinical trial of intranasal somatropin
Read More
Etoricoxib improves quality-of-life measures in osteoarthritis patients
Read More
PhotoCure begins phase III Hexvix program for bladder cancer detection
Read More
Airways effects of Y-27632 and procaterol compared in guinea pigs
Read More
Enrollment in phase II LDP-341 multiple myeloma trial completed ahead of schedule
Read More
Recombinant molecule selected for clinical development as mucositis therapy by Alizyme
Read More
L-Arginine has beneficial effects on blood pressure and erectile dysfunction in rat model
Read More
Agonists at PPAR receptors described by Merck for Rx of diabetes, etc.
Read More
Inhibitors of MMP and/or TNF-alpha reported in patent by Fujisawa
Read More
Fujisawa reveals new antiplatelet agents
Read More
Synthesis and use of nAChR receptor ligands described by AstraZeneca
Read More
Aniline thyroid hormone receptor agonists presented by BMS team
Read More
New pyrimidine compounds and use as chemokine receptor modulators
Read More